Nexperia China moved to reassure customers that production will continue uninterrupted, saying it has secured new wafer suppliers and can meet client demand through to the end of the year and beyond.
The Chinese division of the semiconductor maker said it had “multiple contingency plans” in place, according to a bilingual statement published early Sunday.
The announcement underscored Nexperia China’s efforts to operate independently after Dutch authorities took control of its Netherlands parent from Chinese owner Wingtech in September amid concerns over alleged technology transfers.
Do you have questions about the biggest topics and trends from around the world? Get the answers with [SCMP Knowledge](https://www.scmp.com/knowledge?utm_medium=partner&utm_campaign=contentexchange&utm_so…
Nexperia China moved to reassure customers that production will continue uninterrupted, saying it has secured new wafer suppliers and can meet client demand through to the end of the year and beyond.
The Chinese division of the semiconductor maker said it had “multiple contingency plans” in place, according to a bilingual statement published early Sunday.
The announcement underscored Nexperia China’s efforts to operate independently after Dutch authorities took control of its Netherlands parent from Chinese owner Wingtech in September amid concerns over alleged technology transfers.
Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.
Nexperia last week suspended wafer shipments to its assembly and testing plant in the southern Chinese manufacturing hub of Dongguan - a facility that accounts for about 70 per cent of the company’s global output - citing the local unit’s “failure to comply with the agreed contractual payment terms”.
In the statement, Nexperia China described the Dutch headquarters’ justification for the suspension as “misleading and highly deceptive”.
“Nexperia China has not breached any contracts; on the contrary, Nexperia Netherlands currently owes ATGD over 1 billion yuan (US$140 million) in outstanding payments,” the company said in the statement. ATGD refers to Nexperia’s assembly and testing plant in Dongguan.
It added that the Dutch management team had “put personal interests above the company’s overall interests” and should “bear legal responsibility for the losses inflicted on the company and its employees”.
The Chinese division said the unilateral halt to wafer shipments had “gravely undermined customer trust”, but stressed that production remained stable, citing “sufficient inventories of finished goods and work-in-progress” to meet orders through to the end of the year and beyond.
To ensure longer-term supply resilience, Nexperia China said it was accelerating the qualification of new wafer suppliers, expressing confidence in resuming full capacity next year.
“As a century-old brand, Nexperia’s achievements today are built upon the trust and support of our customers,” the company said, adding that the suspension would “not alter our commitment to product quality and fulfilling customer promises”.